Top Markets
Coin of the day
Aelis Farma S.A. Aelis Farma S.A.

Aelis Farma S.A.

AELIS
Rang in aandelen #30384
Aelis Farma S.A., a French biotechnology company founded in 2013 and... Aelis Farma S.A., a French biotechnology company founded in 2013 and headquartered in Bordeaux, is dedicated to the discovery and development of treatments for brain-related illnesses. The firm's research pipeline primarily focuses on signaling-specific inhibitors that target CB1 receptors. Its leading investigational drug, AEF0117, is currently advancing through Phase 2b clinical trials, designed to alleviate the harmful impacts of excessive cannabis consumption. Furthermore, AEF0217, another key drug candidate, has successfully completed Phase 1 clinical trials, with the goal of addressing cognitive impairments linked to Down syndrome and other similar conditions.
Aandeelprijs
$1.25
Laatst gesynchroniseerd: 2026-08-18
Marktkapitalisatie
$17.05M
Verandering (1 dag)
-1.50%
Verandering (1 jaar)
-22.24%
Land
FR
Handel Aelis Farma S.A. (AELIS)

Categorie

Dividendrendementgeschiedenis voor Aelis Farma S.A. (AELIS)
Het dividendrendement (TTM) van Aelis Farma S.A. (aandelsymbool: AELIS) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Aelis Farma S.A. (AELIS) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten